“…In various dyslipidemia animal models as lipid profile impairment, the α‐LA treatment improved triglyceride levels (Jamor et al, 2018; Mythili et al, 2006; Panda et al, 2017; Pradhan et al, 2014), decreased LDL (Amom et al, 2008; Lukaszuk et al, 2009), increased HDL (Amudha et al, 2007; Carrier et al, 2014; Rideout et al, 2016; Thirunavukkarasu et al, 2004b; Uchendu et al, 2018), and reduced the total plasma cholesterol and free fatty acid (Jacob, Streeper, et al, 1996; E. Kim, Park, Choi, Kim, & Cho, 2008; Okanovic et al, 2015; Ozdogan et al, 2012).…”